- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04820920
Online LTP+CaCBT for Treating Depression in British Mothers of African/Caribbean Heritage
November 22, 2021 updated by: Dr Dung Jidong, PhD, Nottingham Trent University
Online Learning Through Play Plus Culturally Adapted Cognitive Behaviour Therapy (LTP+CaCBT) for Treating Depression in British Mothers of African and Caribbean Heritage: A Pilot Randomised Controlled Trial
The pilot trial aims to test the feasibility, acceptability and cultural appropriateness of online LTP+CaCBT for treating postnatal depression and to improve the mental health and wellbeing of mothers and their children in the UK.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Participants who scored 5 or above on Patient Health Questionnaire (PHQ-9) will be would be recruited and randomly assigned into one of two groups (experimental or controlled).
Experimental groups will receive the online LTP+CaCBT treatment - the intervention will consist of a total of 12 group training sessions (approx.
60 minutes each).
The controlled groups will receive 'placebo effects' in the form of psychoeducation involving basic discussions around mother-child relationships, childcare, child nursing related activities and general maternal discussions.
Each of the two groups (both experimental and controlled) will be comprised of approximately 10 mother-child pairs per sub-group.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dung Jidong, PhD
- Phone Number: +44 115 84 86478
- Email: dung.jidong@ntu.ac.uk
Study Locations
-
-
England
-
Nottingham, England, United Kingdom, NG1 4FQ
- Recruiting
- Nottingham Trent University
-
Contact:
- Dung Jidong, PhD
- Phone Number: +44 115 84 86478
- Email: dung.jidong@ntu.ac.uk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- 18 years and above
- A mother with a child (0-3 years) from the African and/or Caribbean heritage
- Able to provide full consent for their participation
- A resident of the UK
- Able to complete a baseline assessment
- Score 5 or above on Patient Health Questionnaire (PHQ-9)
Exclusion Criteria:
- Less than 18 years
- Medical disorder that would prevent participation in a clinical trial such as Tuberculosis or heart failure
- Temporary residents are unlikely to be available for follow up
- Active suicidal ideation or any other severe mental disorder
- Non-residents of the UK
- Unable to consent
- Patients currently undergoing severe mental health treatment
- Unable to speak the English language fluently
- Other significant physical or learning disability
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LTP+CaCBT
The LTP+CaCBT intervention will consist of 10 (mother-child pairs) participants per sub-group in online group sessions (approx.
60 minutes each) and will deliver one session every fortnight for 12 sessions.
|
LTP is a low-literacy, sustainable programme that will provide depressed mothers with valuable skills on parenting, improve mother-child relation and mental health self-care.
This is a research-based activity that enhances postnatal mental health while simultaneously promoting attachment security through building parents' ability to monitor and be sensitive to their children's cues, and thereby, actively involves in their children's mental and physical development.
Other Names:
CaCBT adopts 'here and now' problem-solving approach, which involves collaborating with families, active listening techniques, changing negative thinking, and depressive symptoms associated with postnatal depression and other forms of parenting distress.
Other Names:
|
|
Active Comparator: Psychoeducation
This is a form of psychoeducation involving basic discussions around mother-child relationships, childcare, child nursing related activities and general maternal discussions.
The psychoeducation would last approximately 60 minutes each for 12 sessions (10 participants per sub-group).
One session would be delivered every fortnight for 12 sessions.
|
This is a form of psychoeducation involving basic discussions around mother-child relationships, childcare, child nursing related activities and general maternal discussions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in postnatal depression is being assessed
Time Frame: Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
Primary outcome measure would be assessed using the Edinburgh Postnatal Depression Scale
|
Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
|
Change in postnatal anxiety is being assessed
Time Frame: Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
Primary outcome measure would be assessed using the Generalised Anxiety Disorder (GAD7) scale
|
Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
|
Change in health is being assessed
Time Frame: Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
Primary outcome measure would be assessed using the Patient Health Questionnaire (PHQ-9)
|
Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
|
Change in social support is being assessed
Time Frame: Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
Primary outcome measures would be assessed using the Oslo Social Support Scale
|
Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
|
Change in health-related quality of life is being assessed
Time Frame: Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
Outcome measure would be assessed using the Health-related Quality of Life scale (EuroQoL-5 Dimensions)
|
Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
|
Change in service satisfaction is being assessed
Time Frame: Change is being assessed at end of intervention, at 3-months and at 6-months post-intervention
|
Outcome measure would be assessed using the brief Verona Service Satisfaction Scale
|
Change is being assessed at end of intervention, at 3-months and at 6-months post-intervention
|
|
Change in child physio-emotional development is being assessed
Time Frame: Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
Outcome measure would be assessed using the Ages and Stages Social-Emotional Questionnaire
|
Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
|
Change in parenting knowledge of child development is being assessed
Time Frame: Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
Outcome measure would be assessed using the Learning through Play (LTP) Knowledge, Attitude and Practices (KAP) Questionnaire
|
Change is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 14, 2021
Primary Completion (Anticipated)
April 30, 2023
Study Completion (Anticipated)
August 30, 2023
Study Registration Dates
First Submitted
March 24, 2021
First Submitted That Met QC Criteria
March 24, 2021
First Posted (Actual)
March 29, 2021
Study Record Updates
Last Update Posted (Actual)
November 24, 2021
Last Update Submitted That Met QC Criteria
November 22, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0000-0001-5034-0335a
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postnatal Depression
-
Lancashire Care NHS Foundation TrustUniversity of ManchesterCompletedDepression, Postpartum | Postnatal Depression in British South Asian WomenUnited Kingdom
-
University of CopenhagenUniversity of AarhusCompletedInfant Social Withdrawal | Maternal Postnatal DepressionDenmark
-
The University of Hong KongEducation Bureau, The Government of the Hong Kong Special Administrative...CompletedPregnancyHong Kong
-
Ministry of Health, MalaysiaCompleted
-
University of MelbourneCompleted
-
Nottingham Trent UniversityNot yet recruiting
-
King's College LondonUniversity College, LondonNot yet recruiting
-
Nottingham Trent UniversitySheffield Hallam University; University of Manchester; Teesside University; University...Not yet recruiting
-
Emily EisnerManchester University NHS Foundation TrustCompleted
-
Pakistan Institute of Living and LearningCompleted
Clinical Trials on LTP
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Pakistan Institute of Living and LearningGrand Challenges CanadaCompleted
-
Novartis PharmaceuticalsRecruitingHealthy Volunteers, Pulmonary Arterial HypertensionUnited States, United Kingdom, France, Italy, Latvia, Germany, Argentina, Australia, Spain, Greece, Brazil, Portugal, Czechia, Romania, Mexico, Belgium, Serbia, Poland
-
Pakistan Institute of Living and LearningGrand Challenges CanadaCompleted
-
Pakistan Institute of Living and LearningUniversity of ManchesterCompletedChild Development | Self-harmPakistan
-
Pakistan Institute of Living and LearningCompleted
-
Pakistan Institute of Living and LearningHealth and Nutrition Development Society; Hincks Dellcrest CentreCompleted
-
Pakistan Institute of Living and LearningCompletedDepression | Intellectual DisabilityPakistan
-
Christopher C. Thompson, MD, MScErbe USA IncorporatedRecruitingUlcer | Nausea | Vomiting | Abdominal Pain | Dysphagia | GastroIntestinal Bleeding | Marginal Ulcer | Roux-en-y Anastomosis Site | Ulcer, Gastric | Marginal Ulcer (Peptic) or Erosion | Ulcer Gastrointestinal | Ulcer GastrojejunalUnited States
-
Pakistan Institute of Living and LearningCompleted